201
Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:July 18, 2012Terminated
Vinorelbine: 523 Clinical Trials, Page 21 of 53
Hide Studies Not Open or Pending
202
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer
Condition(s):Breast CancerLast Updated:April 9, 2013Completed
203
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
Condition(s):Breast NeoplasmsLast Updated:July 18, 2019Completed
204
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer
Condition(s):NSCLCLast Updated:October 4, 2016Completed
205
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Condition(s):Breast CancerLast Updated:June 25, 2012Completed
206
Clinical Trial of Neoadjuvant Targeted Treatment to NSCLC Patients
Condition(s):2-year Disease-Free SurvivalLast Updated:June 29, 2017Not yet recruiting
207
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
Condition(s):Breast; CancerLast Updated:January 7, 2010Completed
208
Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
Condition(s):Breast CancerLast Updated:July 2, 2012Completed
209
Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:August 31, 2016Completed
210
Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
Condition(s):Breast CancerLast Updated:May 15, 2012Completed